Selected research
Industry Research
5-Hydroxytryptamine Receptor 2B Industry Research Report 2026
Market perspective
The global 5-Hydroxytryptamine Receptor 2B market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 5-Hydroxytryptamine Receptor 2B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 5-Hydroxytryptamine Receptor 2B is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 5-Hydroxytryptamine Receptor 2B is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 5-Hydroxytryptamine Receptor 2B include Astellas Pharma Inc, Reviva Pharmaceuticals Inc, RaQualia Pharma Inc, Neurim Pharmaceuticals Ltd, Biofrontera AG and AnaMar AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 5-Hydroxytryptamine Receptor 2B market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
5-Hydroxytryptamine Receptor 2B Market by Company
Astellas Pharma Inc
Reviva Pharmaceuticals Inc
RaQualia Pharma Inc
Neurim Pharmaceuticals Ltd
Biofrontera AG
AnaMar AB
5-Hydroxytryptamine Receptor 2B Segment by Type
DDD-024
INV-240
RP-5063
Others
5-Hydroxytryptamine Receptor 2B Segment by Application
Obesity
Liver Fibrosis
Cirrhosis
Major Depressive Disorder
Others
5-Hydroxytryptamine Receptor 2B Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5-Hydroxytryptamine Receptor 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 5-Hydroxytryptamine Receptor 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5-Hydroxytryptamine Receptor 2B.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 5-Hydroxytryptamine Receptor 2B manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 5-Hydroxytryptamine Receptor 2B by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 5-Hydroxytryptamine Receptor 2B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DDD-024
- INV-240
- RP-5063
- Others
Applications
- Obesity
- Liver Fibrosis
- Cirrhosis
- Major Depressive Disorder
- Others
Companies covered
- Astellas Pharma Inc
- Reviva Pharmaceuticals Inc
- RaQualia Pharma Inc
- Neurim Pharmaceuticals Ltd
- Biofrontera AG
- AnaMar AB
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global 5-Hydroxytryptamine Receptor 2B Market Size (2021-2032)
- 2.2.2 Global 5-Hydroxytryptamine Receptor 2B Sales (2021-2032)
- 2.2.3 Global 5-Hydroxytryptamine Receptor 2B Market Average Price (2021-2032)
- 2.3 5-Hydroxytryptamine Receptor 2B by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DDD-024
- 2.3.3 INV-240
- 2.3.4 RP-5063
- 2.3.5 Others
- 2.4 5-Hydroxytryptamine Receptor 2B by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Obesity
- 2.4.3 Liver Fibrosis
- 2.4.4 Cirrhosis
- 2.4.5 Major Depressive Disorder
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 5-Hydroxytryptamine Receptor 2B Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global 5-Hydroxytryptamine Receptor 2B Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global 5-Hydroxytryptamine Receptor 2B Revenue of Manufacturers (2021-2026)
- 3.4 Global 5-Hydroxytryptamine Receptor 2B Average Price by Manufacturers (2021-2026)
- 3.5 Global 5-Hydroxytryptamine Receptor 2B Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of 5-Hydroxytryptamine Receptor 2B, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of 5-Hydroxytryptamine Receptor 2B, Product Type & Application
- 3.8 Global Manufacturers of 5-Hydroxytryptamine Receptor 2B, Established Date
- 3.9 Global 5-Hydroxytryptamine Receptor 2B Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astellas Pharma Inc
- 4.1.1 Astellas Pharma Inc Company Information
- 4.1.2 Astellas Pharma Inc Business Overview
- 4.1.3 Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astellas Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.1.5 Astellas Pharma Inc Recent Developments
- 4.2 Reviva Pharmaceuticals Inc
- 4.2.1 Reviva Pharmaceuticals Inc Company Information
- 4.2.2 Reviva Pharmaceuticals Inc Business Overview
- 4.2.3 Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Reviva Pharmaceuticals Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.2.5 Reviva Pharmaceuticals Inc Recent Developments
- 4.3 RaQualia Pharma Inc
- 4.3.1 RaQualia Pharma Inc Company Information
- 4.3.2 RaQualia Pharma Inc Business Overview
- 4.3.3 RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 RaQualia Pharma Inc 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.3.5 RaQualia Pharma Inc Recent Developments
- 4.4 Neurim Pharmaceuticals Ltd
- 4.4.1 Neurim Pharmaceuticals Ltd Company Information
- 4.4.2 Neurim Pharmaceuticals Ltd Business Overview
- 4.4.3 Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Neurim Pharmaceuticals Ltd 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.4.5 Neurim Pharmaceuticals Ltd Recent Developments
- 4.5 Biofrontera AG
- 4.5.1 Biofrontera AG Company Information
- 4.5.2 Biofrontera AG Business Overview
- 4.5.3 Biofrontera AG 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Biofrontera AG 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.5.5 Biofrontera AG Recent Developments
- 4.6 AnaMar AB
- 4.6.1 AnaMar AB Company Information
- 4.6.2 AnaMar AB Business Overview
- 4.6.3 AnaMar AB 5-Hydroxytryptamine Receptor 2B Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AnaMar AB 5-Hydroxytryptamine Receptor 2B Product Portfolio
- 4.6.5 AnaMar AB Recent Developments
5 Global 5-Hydroxytryptamine Receptor 2B Market Scenario by Region
- 5.1 Global 5-Hydroxytryptamine Receptor 2B Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global 5-Hydroxytryptamine Receptor 2B Sales by Region: 2021-2032
- 5.2.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Region: 2021-2026
- 5.2.2 Global 5-Hydroxytryptamine Receptor 2B Sales by Region: 2027-2032
- 5.3 Global 5-Hydroxytryptamine Receptor 2B Revenue by Region: 2021-2032
- 5.3.1 Global 5-Hydroxytryptamine Receptor 2B Revenue by Region: 2021-2026
- 5.3.2 Global 5-Hydroxytryptamine Receptor 2B Revenue by Region: 2027-2032
- 5.4 North America 5-Hydroxytryptamine Receptor 2B Market Facts & Figures by Country
- 5.4.1 North America 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2032)
- 5.4.3 North America 5-Hydroxytryptamine Receptor 2B Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe 5-Hydroxytryptamine Receptor 2B Market Facts & Figures by Country
- 5.5.1 Europe 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2032)
- 5.5.3 Europe 5-Hydroxytryptamine Receptor 2B Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific 5-Hydroxytryptamine Receptor 2B Market Facts & Figures by Country
- 5.6.1 Asia Pacific 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2032)
- 5.6.3 Asia Pacific 5-Hydroxytryptamine Receptor 2B Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America 5-Hydroxytryptamine Receptor 2B Market Facts & Figures by Country
- 5.7.1 South America 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2032)
- 5.7.3 South America 5-Hydroxytryptamine Receptor 2B Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Facts & Figures by Country
- 5.8.1 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa 5-Hydroxytryptamine Receptor 2B Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2032)
- 6.1.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global 5-Hydroxytryptamine Receptor 2B Sales Market Share by Type (2021-2032)
- 6.2 Global 5-Hydroxytryptamine Receptor 2B Revenue by Type (2021-2032)
- 6.2.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global 5-Hydroxytryptamine Receptor 2B Revenue Market Share by Type (2021-2032)
- 6.3 Global 5-Hydroxytryptamine Receptor 2B Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2032)
- 7.1.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global 5-Hydroxytryptamine Receptor 2B Sales Market Share by Application (2021-2032)
- 7.2 Global 5-Hydroxytryptamine Receptor 2B Revenue by Application (2021-2032)
- 7.2.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global 5-Hydroxytryptamine Receptor 2B Revenue Market Share by Application (2021-2032)
- 7.3 Global 5-Hydroxytryptamine Receptor 2B Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 5-Hydroxytryptamine Receptor 2B Value Chain Analysis
- 8.1.1 5-Hydroxytryptamine Receptor 2B Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 5-Hydroxytryptamine Receptor 2B Production Mode & Process
- 8.2 5-Hydroxytryptamine Receptor 2B Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 5-Hydroxytryptamine Receptor 2B Distributors
- 8.2.3 5-Hydroxytryptamine Receptor 2B Customers
9 Global 5-Hydroxytryptamine Receptor 2B Analyzing Market Dynamics
- 9.1 5-Hydroxytryptamine Receptor 2B Industry Trends
- 9.2 5-Hydroxytryptamine Receptor 2B Industry Drivers
- 9.3 5-Hydroxytryptamine Receptor 2B Industry Opportunities and Challenges
- 9.4 5-Hydroxytryptamine Receptor 2B Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst